# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-131534
Filing Date
2021-04-26
Accepted
2021-04-26 16:22:01
Documents
7
Period of Report
2021-05-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d140648ddef14a.htm | DEF 14A | 1069491
2 | GRAPHIC | g140648dsp001.jpg | GRAPHIC | 115068
3 | GRAPHIC | g140648dsp002.jpg | GRAPHIC | 186034
4 | GRAPHIC | g140648dsp003.jpg | GRAPHIC | 128513
5 | GRAPHIC | g140648dsp004.jpg | GRAPHIC | 161821
6 | GRAPHIC | g140648dsp005.jpg | GRAPHIC | 169061
7 | GRAPHIC | g140648dsp006.jpg | GRAPHIC | 161398
| Complete submission text file | 0001193125-21-131534.txt |  | 2341168

Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36697 | Film No.: 21854113
SIC: 2836 Biological Products, (No Diagnostic Substances)